Literature DB >> 25647260

Association of HPV with genetic and epigenetic alterations in colorectal adenocarcinoma from Indian population.

Ruhina S Laskar1, Fazlur R Talukdar, Javed H Choudhury, Seram Anil Singh, Sharbadeb Kundu, Bishal Dhar, Rosy Mondal, Sankar Kumar Ghosh.   

Abstract

Several studies from developing countries have shown human papillomavirus to be associated with colorectal cancers, but the molecular characteristics of such cancers are poorly known. We studied the various genetic variations like microsatellite instability (MSI), oncogenic mutations and epigenetic deregulations like CpG island methylation in HPV associated and nonassociated colorectal cancer patients from Indian population. HPV DNA was detected by PCR using My09/My11 and Gp5+/Gp6+ consensus primers and typed using HPV16 and HPV18 specific primers. MSI was detected using BAT 25 and BAT 26 markers, and mutation of KRAS, TP53 and BRAF V600E were detected by direct sequencing. Methyl specific polymerase chain reaction (MSP) was used to determine promoter methylation of the classical CIMP panel markers (P16, hMLH1, MINT1, MINT2 and MINT31) and other tumour-related genes (DAPK, RASSF1, BRCA1 and GSTP1). HPV DNA was detected in 34/93 (36.5 %) colorectal tumour tissues, HPV 18 being the predominant high-risk type. MSI was detected in 7.5 % cases; KRAS codon 12, 13, BRAF V600E and TP53 mutations were detected in 36.5, 3.2 and 37.6 % of the cases, respectively. CIMP-high was observed in 44.08 % cases. HPV presence was not associated with age, stage or grade of tumours, MSI or mutations in KRAS, TP53 or BRAF genes. Higher methylation frequencies of all genes/loci under study except RASSF1, as well as significantly higher CIMP-high characteristics were observed in HPV positive tumours as compared to negative cases. HPV in association with genetic and epigenetic features might be a potent risk factor for colorectal cancer in Indian population.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25647260     DOI: 10.1007/s13277-015-3114-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  46 in total

1.  Transmission of carcinogenic human papillomavirus types from mother to child: a meta-analysis of published studies.

Authors:  Mireille Merckx; Wildero-Van Wouwe Liesbeth; Marc Arbyn; Joris Meys; Steven Weyers; Marleen Temmerman; Davy Vanden Broeck
Journal:  Eur J Cancer Prev       Date:  2013-05       Impact factor: 2.497

2.  Oncogenic human papillomavirus imposes an instructive pattern of DNA methylation changes which parallel the natural history of cervical HPV infection in young women.

Authors:  Sarah M Leonard; Wenbin Wei; Stuart I Collins; Merlin Pereira; Afaf Diyaf; Christothea Constandinou-Williams; Lawrence S Young; Sally Roberts; Ciarán B Woodman
Journal:  Carcinogenesis       Date:  2012-05-02       Impact factor: 4.944

Review 3.  Genetic predisposition to colorectal cancer.

Authors:  Albert de la Chapelle
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

4.  Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer.

Authors:  Patti Kay; Bruce Allan; Lynette Denny; Margaret Hoffman; Anna-Lise Williamson
Journal:  J Med Virol       Date:  2005-03       Impact factor: 2.327

5.  Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene.

Authors:  M Dürst; D Gallahan; G Jay; J S Rhim
Journal:  Virology       Date:  1989-12       Impact factor: 3.616

6.  Analysis of adenocarcinoma of the colon and rectum: detection of human papillomavirus (HPV) DNA by polymerase chain reaction.

Authors:  L O Pérez; M C Abba; R M Laguens; C D Golijow
Journal:  Colorectal Dis       Date:  2005-09       Impact factor: 3.788

7.  Association of mitochondrial D-loop mutations with GSTM1 and GSTT1 polymorphisms in oral carcinoma: a case control study from northeast India.

Authors:  Rosy Mondal; Sankar Kumar Ghosh; Fazlur Rahman Talukdar; Ruhina Shirin Laskar
Journal:  Oral Oncol       Date:  2012-12-20       Impact factor: 5.337

8.  Detection of viral DNA sequences in sporadic colorectal cancers in relation to CpG island methylation and methylator phenotype.

Authors:  Pawel Karpinski; Aleksander Myszka; David Ramsey; Wojciech Kielan; Maria Malgorzata Sasiadek
Journal:  Tumour Biol       Date:  2011-04-06

9.  Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma.

Authors:  Matthias Lechner; Tim Fenton; James West; Gareth Wilson; Andrew Feber; Stephen Henderson; Christina Thirlwell; Harpreet K Dibra; Amrita Jay; Lee Butcher; Ankur R Chakravarthy; Fiona Gratrix; Nirali Patel; Francis Vaz; Paul O'Flynn; Nicholas Kalavrezos; Andrew E Teschendorff; Chris Boshoff; Stephan Beck
Journal:  Genome Med       Date:  2013-02-05       Impact factor: 11.117

10.  Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion.

Authors:  Neel Sengupta; Christopher Yau; Anuratha Sakthianandeswaren; Dmitri Mouradov; Peter Gibbs; Nirosha Suraweera; Jean-Baptiste Cazier; Guadalupe Polanco-Echeverry; Anil Ghosh; Mohamed Thaha; Shafi Ahmed; Roger Feakins; David Propper; Sina Dorudi; Oliver Sieber; Andrew Silver; Cecilia Lai
Journal:  Mol Cancer       Date:  2013-01-03       Impact factor: 27.401

View more
  3 in total

Review 1.  The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer.

Authors:  Dan Gao; James G Herman; Mingzhou Guo
Journal:  Oncotarget       Date:  2016-06-14

Review 2.  Epigenetic heterogeneity in cancer.

Authors:  Mingzhou Guo; Yaojun Peng; Aiai Gao; Chen Du; James G Herman
Journal:  Biomark Res       Date:  2019-10-31

3.  Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer.

Authors:  Shailesh Mahesh Advani; Pragati Shailesh Advani; Derek W Brown; Stacia M DeSantis; Krittiya Korphaisarn; Helena M VonVille; Jan Bressler; David S Lopez; Jennifer S Davis; Carrie R Daniel; Amir Mehrvarz Sarshekeh; Dejana Braithwaite; Michael D Swartz; Scott Kopetz
Journal:  BMC Cancer       Date:  2019-10-17       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.